Cup and Handle Earnings 10-22 BMO

NYSE:DGX   Quest Diagnostics Incorporated
DGX fell from a bearish rising wedge and forming a CUP and Handle pattern
C&H patterns are only valid over long entry level
Earnings are tomorrow BMO
Possible stop under 116
NV is increasing

Short interest is low
Possible Target 2 159.3 166.6 (Long Term)

Risky to trade before earnings

This one seems to be in the right place at the right time..but who knows?
A company can beat earnings and go down, or miss and go up

Not a recommendation

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationships with Clinical Genomics Pty Ltd and Anthem Inc . The company was founded in 1967 and is headquartered in Secaucus, New Jersey.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.